Fresenius Medical Care AG
FMS
$23.92
$0.100.42%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 37.18% | 27.00% | 106.59% | -64.75% | 155.09% |
| Total Depreciation and Amortization | 2.38% | -0.53% | -4.35% | -2.90% | -4.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -7.63% | -- |
| Total Other Non-Cash Items | 115.83% | 58.93% | -84.79% | 2,282.58% | -198.97% |
| Change in Net Operating Assets | -82.39% | 161.64% | 11.31% | 75.94% | 64.40% |
| Cash from Operations | -19.92% | 84.69% | 23.98% | 14.52% | 30.91% |
| Capital Expenditure | -23.62% | -2.11% | -5.52% | 4.78% | -22.10% |
| Sale of Property, Plant, and Equipment | 107.52% | 31.66% | -23.76% | -34.06% | -240.55% |
| Cash Acquisitions | 73.53% | -46.77% | -777.29% | 1.16% | -88.42% |
| Divestitures | 13,946.28% | -99.75% | -53.80% | -13.79% | 344.57% |
| Other Investing Activities | 93.16% | -36.69% | 0.83% | -43.15% | -263.14% |
| Cash from Investing | 73.89% | -146.44% | -53.48% | -22.30% | -47.01% |
| Total Debt Issued | 1,269.44% | 1,482.15% | -64.25% | 27.55% | 103.29% |
| Total Debt Repaid | -71.53% | -44.78% | 65.38% | -32.52% | -118.13% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -27.60% | -- | -- | -- |
| Other Financing Activities | -332.94% | -81.25% | -15.36% | -93.96% | -24.84% |
| Cash from Financing | -153.05% | 109.98% | 53.55% | -28.17% | -16.87% |
| Foreign Exchange rate Adjustments | -39.51% | -864.99% | -381.77% | 309.16% | -174.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -279.18% | 944.23% | 56.05% | -35.86% | 30.53% |